Paul Mieyal is the Managing Director at Outcome Capital, a position he has held since April 2021. Based in the United States, Paul brings extensive experience in life sciences investments and strategic advisory roles. Prior to joining Outcome Capital, he served as Principal at Life Sciences Investor: The Buy Side Experience from January to April 2021.

Paul's career includes significant tenures such as Managing Director, Life Sciences Investments at Wexford Capital LP from October 2006 to December 2020, and CEO of Nephros, Inc. from April 2010 to May 2012. He also held the role of Strategic Advisor at Raadysan Biotech, Inc. from August 2016 to November 2020 and Vice President at Wechsler & Co., Inc. from January 2000 to September 2006.

Paul's extensive background in investment banking and life sciences underscores his expertise and leadership in the industry.